Towa Pharmaceutical Revenue

Towa Pharmaceutical had revenue of 60.84B JPY in the quarter ending September 30, 2024, with 15.12% growth. This brings the company's revenue in the last twelve months to 243.94B, up 8.06% year-over-year. In the fiscal year ending March 31, 2024, Towa Pharmaceutical had annual revenue of 227.93B with 9.13% growth.

Revenue (ttm)

243.94B

Revenue Growth

+8.06%

P/S Ratio

0.65

Revenue / Employee

53.17M

Employees

4,588

Market Cap

158.51B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2024	227.93B	19.08B	9.13%
Mar 31, 2023	208.86B	43.24B	26.11%
Mar 31, 2022	165.62B	10.72B	6.92%
Mar 31, 2021	154.90B	44.52B	40.33%
Mar 31, 2020	110.38B	5.28B	5.02%
Mar 31, 2019	Pro	Pro	Pro
Mar 31, 2018	Pro	Pro	Pro
Mar 31, 2017	Pro	Pro	Pro
Mar 31, 2016	Pro	Pro	Pro
Mar 31, 2015	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Chugai Pharmaceutical	1,142.35B
Daiichi Sankyo Company	1,758.07B
HOYA Corporation	812.74B
Takeda Pharmaceutical Company	4,546.08B
Terumo	986.67B
Otsuka Holdings	2,269.56B
Astellas Pharma	1,772.16B
Olympus	973.60B

Revenue Rankings